These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9096988)

  • 21. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.
    van Bon AC; Dragt D; DeVries JH
    Diabetes Technol Ther; 2012 May; 14(5):447-8. PubMed ID: 22548715
    [No Abstract]   [Full Text] [Related]  

  • 22. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
    Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?
    Giménez M; Purkayajtha S; Moscardó V; Conget I; Oliver N
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):182-184. PubMed ID: 29429951
    [No Abstract]   [Full Text] [Related]  

  • 24. Programmable implantable insulin infusion devices and diabetes care.
    Charles MA
    Diabetes Technol Ther; 1999; 1(1):89-96. PubMed ID: 11475311
    [No Abstract]   [Full Text] [Related]  

  • 25. A preliminary trial of the programmable implantable medication system for insulin delivery.
    Saudek CD; Selam JL; Pitt HA; Waxman K; Rubio M; Jeandidier N; Turner D; Fischell RE; Charles MA
    N Engl J Med; 1989 Aug; 321(9):574-9. PubMed ID: 2761602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cecum erosion: unusual but serious complication of an implanted catheter for peritoneal insulin delivery.
    Renard E; Taourel P; Quenet F; Domergue J; Bruel JM; Bringer J
    Diabetes Care; 1995 Mar; 18(3):408-9. PubMed ID: 7555488
    [No Abstract]   [Full Text] [Related]  

  • 28. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
    Renard E; Guerci B; Leguerrier AM; Boizel R;
    Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
    Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of an elastomeric continuous infusion device to maintain catheter patency.
    Heath J; Jones S
    J Intraven Nurs; 2001; 24(2):102-6. PubMed ID: 11836834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A
    Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy.
    Morris M; Phares K; Zaccardelli D; Ujhelyi MR
    J Vasc Access; 2008; 9(1):20-7. PubMed ID: 18379976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful pregnancy in I.D.D.M. with intravenous programmable insulin pump.
    Brosnan E; Devlin JG
    Ir J Med Sci; 1994 Feb; 163(2):56-7. PubMed ID: 8200770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects and indwelling times of subcutaneous catheters for insulin injections: a new device for injecting insulin with a minimum of pain in the treatment of insulin-dependent diabetes mellitus.
    Hanas R; Ludvigsson J
    Diabetes Res Clin Pract; 1990; 10(1):73-83. PubMed ID: 2249606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aseptic peritonitis revealed through recurrent catheter obstructions in type 1 diabetic patients treated with continuous peritoneal insulin infusion.
    Renard E; Raingeard I; Costalat G; Apostol D; Lauton D; Boulet F; Bringer J
    Diabetes Care; 2004 Jan; 27(1):276-7. PubMed ID: 14694006
    [No Abstract]   [Full Text] [Related]  

  • 37. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters.
    Peynircioglu B; Ozkan F; Canyigit M; Cil BE; Balkanci F
    Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump.
    Haveman JW; Logtenberg SJ; Kleefstra N; Groenier KH; Bilo HJ; Blomme AM
    Langenbecks Arch Surg; 2010 Jan; 395(1):65-71. PubMed ID: 19048281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scintigraphic monitoring of catheter-port systems in type I diabetics with continuous insulin therapy.
    Lindner O; Klein E; Franzke K; Petzoldt R; Burchert W
    Exp Clin Endocrinol Diabetes; 2004 Mar; 112(3):148-52. PubMed ID: 15052535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.